Cargando…
In Silico Drug Repurposing in Multiple Sclerosis Using scRNA-Seq Data
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system still lacking a cure. Treatment typically focuses on slowing the progression and managing MS symptoms. Single-cell transcriptomics allows the investigation of the immune system—the key player in MS onset and development—i...
Autores principales: | Shevtsov, Andrey, Raevskiy, Mikhail, Stupnikov, Alexey, Medvedeva, Yulia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864606/ https://www.ncbi.nlm.nih.gov/pubmed/36674506 http://dx.doi.org/10.3390/ijms24020985 |
Ejemplares similares
-
ScRNA-seq and ST-seq in liver research
por: He, Jia, et al.
Publicado: (2023) -
Inference of differential key regulatory networks and mechanistic drug repurposing candidates from scRNA-seq data with SCANet
por: Oubounyt, Mhaned, et al.
Publicado: (2023) -
scRNASequest: an ecosystem of scRNA-seq analysis, visualization, and publishing
por: Li, Kejie, et al.
Publicado: (2023) -
Repurposable drugs for SARS-CoV-2 and influenza sepsis with scRNA-seq data targeting post-transcription modifications
por: Wang, Zhihan, et al.
Publicado: (2021) -
Computational approaches for interpreting scRNA‐seq data
por: Rostom, Raghd, et al.
Publicado: (2017)